Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience-Reference-Cited by-同舟云学术

Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience

Published:2014-03-10 Issue:11 Volume:55 Page:2497-2501
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Wang Xiao-xiao¹²³,Huang Hui-qiang¹²³,Bai Bing¹²³,Cai Qing-qing¹²³,Cai Qi-chun¹²³,Gao Yan¹²³,Xia Yun-fei⁴²³,Xia Zhong-jun¹²³,Jiang Wen-qi¹²³

Affiliation:

1. Departments of Medical Oncology, Sun Yat-sen University Cancer Center

2. State Key Laboratory of Oncology in South China

3. Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China

4. Departments of Radiation Oncology, Sun Yat-sen University Cancer Center

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.889823

Reference33 articles.

1. Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315

2. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome

3. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.

4. Long-term survival in primary CNS lymphoma.

5. Primary central nervous system lymphoma – Biological aspects and controversies in management

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study on primary central nervous system lymphoma in pediatric patients;Child's Nervous System;2023-07-04

2. Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma;Scientific Reports;2022-12-13

3. Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis;Hematological Oncology;2021-09-26

4. Nanomedicine Applications in Treatment of Primary Central Nervous System Lymphoma: Current State of the Art;Journal of Biomedical Nanotechnology;2021-08-01

5. Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy;Annals of Hematology;2020-08-20